套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-23-014422 Act: 34 Size: 4 MB 网页链接
$Lyra Therapeutics(LYRA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-083819 Act: 33 Size: 88 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-010632 Act: 34 Size: 14 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0000950170-23-010621 Act: 34 Size: 9 MB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-006395 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-23-006393 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021843 Act: 34 Size: 45 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021762 Act: 34 Size: 293 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001590144-23-000019 Act: 34 Size: 10 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035881 Act: 34 Size: 94 KB 网页链接